ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases
Guardado en:
Autores principales: | Yuan Liu, Bin Wang, Shiju Chen, Guixiu Shi, Hongyan Qian, Guomei Yang, Jinying Lan, Fan Dai, Peishi Rao, Puqi Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31e1bf93ae19491997d37bd0430df3d4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases
por: Omar Suhail Alsaed, et al.
Publicado: (2021) -
Video Scene Information Detection Based on Entity Recognition
por: Hui Qian, et al.
Publicado: (2021) -
LEGAL ANALYSIS OF THE POSITION OF VILLAGE OWNED BUSINESS ENTITIES AS A LEGAL ENTITY AFTER THE ENTRY OF LAW NUMBER 11 YEAR 2020 CONCERNING WORK CREATION
por: Alting H., et al.
Publicado: (2021) -
Social Identity and Legal Personality – Collective Entities as Legal Entities?
por: Miodrag Jovanović
Publicado: (2016) -
Social Identity and Legal Personality – Collective Entities as Legal Entities?
por: Miodrag Jovanović
Publicado: (2016)